Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OFATUMUMAB vs OLECLUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OFATUMUMAB vs OLECLUMAB: Safety Overview

Metric OFATUMUMAB OLECLUMAB
Total FAERS Reports 29,913 118
Deaths Reported 695 14
Death Rate 2.3% 11.9%
Hospitalizations 3,616 102
Average Patient Age 47.5 yrs 63.4 yrs
% Female Patients 74.9% 41.7%
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A